يعرض 1 - 10 نتائج من 65 نتيجة بحث عن '"Irlam, Joely"', وقت الاستعلام: 0.96s تنقيح النتائج
  1. 1
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: https://orca.cardiff.ac.uk/id/eprint/164751/1/PIIS0360301623081841.pdfTest; Thomson, David, Slevin, Nick, Baines, Helen, Betts, Guy, Bolton, Steve, Evans, Mererid https://orca.cardiff.ac.uk/view/cardiffauthors/A2268810Z.htmlTest, Garcez, Kate, Irlam, Joely, Lee, Lip, Melillo, Nicola, Mistry, Hitesh, More, Elisabet, Nutting, Christopher, Price, James, Schipani, Stefano, Sen, Mehmet, Yang, Huiqi and West, Catharine 2023. Randomised phase III trial of the hypoxia modifier nimorazole added to radiotherapy with benefit assessed in hypoxic head and neck cancers determined using a gene signature (NIMRAD). International Journal of Radiation Oncology - Biology - Physics 10.1016/j.ijrobp.2023.11.055 https://doi.org/10.1016/j.ijrobp.2023.11.055Test Item availability restricted. file

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية

    المؤلفون: Eyers, Michael1 (AUTHOR) Michael.eyres@md.catapult.org.uk, Irlam, Joely2 (AUTHOR), Marshall, Gayle1 (AUTHOR), Smith, Vicky3 (AUTHOR), Baker, Alexander3 (AUTHOR), Frost, Lucy1 (AUTHOR), Hoskin, Peter2,4 (AUTHOR), Choudhury, Ananya2,5 (AUTHOR), West, Catharine2 (AUTHOR)

    المصدر: Communications Biology. 6/18/2024, Vol. 7 Issue 1, p1-10. 10p.

  4. 4
    دورية أكاديمية

    المصدر: Song , Y P , Mistry , H , Irlam , J , Valentine , H , Yang , L , Lane , B , West , C , Choudhury , A & Hoskin , P J 2021 , ' Long-Term Outcomes of Radical Radiation Therapy with Hypoxia Modification with Biomarker Discovery for Stratification: 10-Year Update of the BCON (Bladder Carbogen Nicotinamide) Phase 3 Randomized Trial (ISRCTN45938399) ' , International Journal of Radiation: Oncology - Biology - Physics . https://doi.org/10.1016/j.ijrobp.2021.03.001Test

    وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document

  5. 5
    مؤتمر

    المساهمون: The Christie NHS Foundation Trust, Manchester, United Kingdom

    العلاقة: https://dx.doi.org/10.1200/JCO.2023.41.16_suppl.6006Test; Thomson D, Slevin N, Baines H, Betts G, Bolton S, Evans M, et al. Randomised phase III trial of the hypoxia modifier nimorazole added to radiotherapy with benefit assessed in hypoxic head and neck cancers determined using a gene signature (NIMRAD). Journal of Clinical Oncology. 2023 Jun;41(16). PubMed PMID: WOS:001053772003127.; http://hdl.handle.net/10541/626645Test; Journal of Clinical Oncology

  6. 6
    دورية أكاديمية

    المصدر: Smith , T , Abdelkarem , O A I , Irlam , J , Lane , B , Valentine , H , Bibby , B , Denley , H , Choudhury , A & West , C 2020 , ' Selection of endogenous control genes for normalising gene expression data derived from formalin-fixed paraffin-embedded tumour tissue ' , Nature -London- . https://doi.org/10.1038/s41598-020-74380-7Test

  7. 7

    المصدر: Little, R, Jamin, Y, Boult, J K R, Naish, J, Watson, Y, Cheung, S, Holliday, K, Lu, H, Mchugh, D, Irlam, J, West, C, Betts, G, Ashton, G, Reynolds, A R, Maddineni, S, Clarke, N W, Parker, G JM, Waterton, J, Robinson, S P & O'Connor, J 2018, ' Mapping Hypoxia in Renal Carcinoma with Oxygen-enhanced MRI : Comparison with Intrinsic Susceptibility MRI and Pathology ', Radiology, vol. 288, no. 3, pp. 739-747 . https://doi.org/10.1148/radiol.2018171531Test

  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية

    المصدر: Forker , L , Gaunt , P , Sioletic , S , Shenjere , P , Potter , R , Roberts , D , Irlam , J , Valentine , H , Hughes , D , Hughes , A , Billingham , L , Grimer , R , Seddon , B , Choudhury , A , Robinson , M & West , C 2017 , ' The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma ' , British Journal of Cancer . https://doi.org/10.1038/bjc.2017.430Test

  10. 10
    دورية أكاديمية

    المصدر: Yang , L , Taylor , J , Eustace , A , Irlam , J , Denley , H , Hoskin , P , Alsner , J , Buffa , F M , Harris , A L , Choudhury , A & West , C 2017 , ' A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High Risk Bladder Cancer Patients ' , Clinical Cancer Research , vol. 23 , no. 16 , pp. 4761-4768 . https://doi.org/10.1158/1078-0432.CCR-17-0038Test

    وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document